Health
Researchers investigate the duration of the immune response to SARS-CoV-2 – News-Medical.Net
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration…
The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study.
The research also reveals that the ideal convalescent plasma donor is a recovered COVID-19 patient who is older than 30 and whose illness had been severe.
Millions of individuals worldwide have recovered from COVID-19 and may be…
-
Noosa News24 hours agoAbusive bus driver fired by council loses appeal
-
General20 hours agoIran’s currency at record low as tensions run high
-
General24 hours agoTwo groups of men evicted from Rabbitohs and Roosters NRL clash after wild brawl
-
General19 hours agoLabor to pledge $2.3 billion to subsidise home batteries